Skip to main content

Renal Transplantation

Renal Transplantation

Immunosuppressive Medications

Wiseman AC
Clin J Am Soc Nephrol. 2016 Feb 5; 11(2): 332–343

Long-term risks for kidney donors

Geir Mjøen, Stein Hallan, Anders Hartmann, Aksel Foss, Karsten Midtvedt, Ole Øyen, Anna Reisæter, Per Pfeffer, Trond Jenssen, Torbjørn Leivestad, Pål- Dag Line, Magnus Øvrehus, Dag Olav Dale, Hege Pihlstrøm, Ingar Holme, Friedo W Dekker and Hallvard Holda
Kidney Int. 2013 Nov 27.

Long-term consequences of kidney donation

Hassan N. Ibrahim, M.D., Robert Foley, M.B., B.S., LiPing Tan, M.D., Tyson Rogers, M.S., Robert F. Bailey, L.P.N., Hongfei Guo, Ph.D., Cynthia R. Gross, Ph.D., and Arthur J. Matas, M.D.
N Engl J Med. 2009 Jan 29;360(5):459-69

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N; DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Moni
Am J Transplant. 2007 Jun;7(6):1506-14

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group
N Engl J Med. 2006 Nov 9;355(19):1967-77
ukidneyisup